Tigecycline for treatment of carbapenem-resistant Klebsiella pneumoniae infections after liver transplantation in the intensive care unit: a 3-year study.
暂无分享,去创建一个
E. Iosifidis | V. Papanikolaou | E. Mouloudi | E. Massa | I. Fouzas | S. Papadopoulos | G. Imvrios | C. Kydona | N. Gritsi-Gerogianni | M. Piperidou | I. Roilides | T. Theodoridou
[1] M. Bartels,et al. Colonization of liver transplant recipients with KPC-producing Klebsiella pneumoniae is associated with high infection rates and excess mortality: a case–control analysis , 2014, Infection.
[2] M. Falagas,et al. Antibiotic Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae: Systematic Evaluation of the Available Evidence , 2013, Antimicrobial Agents and Chemotherapy.
[3] W. Heizmann,et al. Therapy of 1,025 Severely Ill Patients with Complicated Infections in a German Multicenter Study: Safety Profile and Efficacy of Tigecycline in Different Treatment Modalities , 2012, Chemotherapy.
[4] G. Daikos,et al. Carbapenemases in Klebsiella pneumoniae and Other Enterobacteriaceae: an Evolving Crisis of Global Dimensions , 2012, Clinical Microbiology Reviews.
[5] T. Schiano,et al. Mortality associated with carbapenem‐resistant Klebsiella pneumoniae infections in liver transplant recipients , 2012, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[6] D. O. Garcia,et al. Infection with Klebsiella pneumoniae carbapenemase (KPC)‐producing K. pneumoniae in solid organ transplantation , 2012, Transplant infectious disease : an official journal of the Transplantation Society.
[7] M. Rela,et al. Mortality associated with carbapenem‐resistant Klebsiella pneumoniae infections in liver transplant recipients , 2012, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[8] R. Guner,et al. Outcomes in patients infected with carbapenem-resistant Acinetobacter baumannii and treated with tigecycline alone or in combination therapy , 2011, Infection.
[9] E. Roilides,et al. Bloodstream Infections Caused by Metallo-β-Lactamase/Klebsiella pneumoniae Carbapenemase–Producing K. pneumoniae among Intensive Care Unit Patients in Greece: Risk Factors for Infection and Impact of Type of Resistance on Outcomes , 2010, Infection Control & Hospital Epidemiology.
[10] Arthur J. L. Cooper,et al. Safety and efficacy of intravenous tigecycline in subjects with secondary bacteremia: pooled results from 8 phase III clinical trials. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[11] Gopi Patel,et al. Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Infection and the Impact of Antimicrobial and Adjunctive Therapies , 2008, Infection Control & Hospital Epidemiology.